Founded in 1849 as a leading global medical solutions brand originating from Sweden, Molnlycke focuses on wound care and is known for its innovative technology and high-quality products to provide healthcare professionals with the best patient outcomes, clinical outcomes and economic benefits. Its core patented Safetac® soft polysilicone adhesive technology allows for painless and non-invasive dressing changes, significantly reducing the risk of secondary wound injury. Its products include Mepilex (pressure ulcer prevention and exudate management), Mepilex (scar repair), Menova (debridement gel) and other series, which are widely used in chronic wounds, burns and post-operative care. At present, its business covers nearly 100 countries around the world, and it continues to promote the development of medical care with the mission of "reducing the burden of wounds".